ARCH Venture Management, LLC
CHICAGO IL · SEC CIK 0001274403
$11.00亿2026Q2 申报市值
12持仓数
99.3%前十大占比 · 第一大 16.0%
3 / 1新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q2 买入最多 按季末市值估算
PBLS 新建仓+$1.76亿
SPTX 新建仓+$1.37亿
BOUNDLESS BIO IN 新建仓+$673.52万
2026Q2 卖出最多 按季末市值估算
VIR 减仓-$226.73万
QTTB 清仓-$205.75万
2026Q2 持仓明细 点表头排序
导出 CSV 🔒| 代码 | 名称 | 市值 ▼ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| PBLS | PARABILIS MEDICINES INC | $1.76亿 | 15.95% | 6,412,780 | 6,412,780 | — | $1.76亿 | 新建仓 |
| BEAM | BEAM THERAPEUTICS INC | $1.56亿 | 14.16% | 4,540,132 | 0 | 0.0% | — | 不变 |
| RAPP | RAPPORT THERAPEUTICS INC | $1.55亿 | 14.12% | 3,728,738 | 0 | 0.0% | — | 不变 |
| SPTX | SEAPORT THERAPEUTICS INC | $1.37亿 | 12.42% | 6,294,951 | 6,294,951 | — | $1.37亿 | 新建仓 |
| ERAS | ERASCA INC | $1.30亿 | 11.81% | 7,091,557 | 0 | 0.0% | — | 不变 |
| VIR | VIR BIOTECHNOLOGY INC | $1.29亿 | 11.76% | 12,694,163 | -222,500 | -1.7% | -$226.73万 | 减仓 |
| MAZE | MAZE THERAPEUTICS INC | $1.23亿 | 11.18% | 4,120,053 | 0 | 0.0% | — | 不变 |
| LYEL | LYELL IMMUNOPHARMA INC | $4,552.52万 | 4.14% | 3,247,162 | 0 | 0.0% | — | 不变 |
| GENB | GENERATE BIOMEDICINES INC | $3,280.25万 | 2.98% | 1,944,426 | 0 | 0.0% | — | 不变 |
| TXG | 10X GENOMICS INC | $835.18万 | 0.76% | 217,834 | 0 | 0.0% | — | 不变 |
| — | BOUNDLESS BIO INC | $673.52万 | 0.61% | 2,694,095 | 2,694,095 | — | $673.52万 | 新建仓 |
| — | GOSSAMER BIO INC | $132.60万 | 0.12% | 8,055,916 | 0 | 0.0% | — | 不变 |
| QTTB | Q32 BIO INC | $0 | 0.00% | 0 | -320,482 | -100.0% | -$205.75万 | 清仓 |